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We have previously reported that carbamoylcholine (earbachol), a recognized inhibitor of somatostatin release from D-cells, can act as stimulant following pretreatment of cells with pertussis toxin.
In the present studies we have observed that pertussis toxin reverses the inhibitory effects of carbachol on D-cell stimulated with either cAMP or 12-0-tetradecanoyl-phorbol 13-acetate.
Furthermore, the stimulatory effects of carbachol on D-cells pretreated with pertussis toxin potentiated the actions of pentagastrin without further enhancing the release of 3H-inositol trisphosphate from prelabeled cells. These studies suggest that carbachol exerts its inhibitory effects on D-cells via pertussis toxin sensitive guaninine nucleotide binding proteins at a point distal to the activation of different signal transduction mechanisms and that the stimulatory effects of carbachol are mediated by mechanisms that are independent of membrane phosphoinositide turnover.
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In previous studies we have demonstrated that carbachol, an inhibitor of somatostatin release from gastric D-cells under normal circumstances (I), can stimulate D-cells after pertussis toxin pretreatment (2) . The decreased cellular production of adenosine 3':5'-cyclic monophosphate (cAMP) and enhanced turnover of membrane inositol phospholipids that accompany carbachol action on D-cells suggest possible mechanisms for, respectively, the inhibitory and stimulatory effects that were observed. We undertook these studies to further explore the potential mechanisms for muscarinic regulation of D-cells. described previously (1,3). Somatostatin containing D-cells were further enriched by centrifugal elutriation and then cultured at a concentration 4 x 10 cells/well on a bed of collagen in Ham's F12-Dulbecco's modified Eagle's medium (50:50, vol/vol) containing 10% dog serum, insulin (8 ug/ml) and hydrocortisone (I ug/ml) in the presence of 95% air -5% CO 2 at 37 ° C. After 40h of stabilization, the cells were incubated in Earle's balanced salt solution containing various test substances for a subsequent 2h experiment and somatostatin released into the media was measured by radioimmunoassay as described previously (4) . Some experiments were performed after the cells had been preincubated with pertussis toxin (200 ng/ml) for 4h.
MATERIALS AND METHODS

Materials
Production of 3H-IPq: Turnover of membrane inositol phospholipids was assessed by measurifig the release of ~H-IP, from D-cells after first prelabeling for 24h at 37 ° in culture medidm (see above) containing 3H-inositol (20 uCi/well). During the last 15 min of incubation, lithium chloride was added to achieve a final concentration of 10 mM. Following the prelabeling period, the cells were further incubated for 5 min in I ml of Earle's balanced salt solution containing various test substances. The incubation~ were terminated by the addition of 3 ml of chloroform:methanol (1:2) and jH-IP~ was separated by Dowex-resin chromatography using the method of Fisher and B~rtus (5). The fractions denoted as containing IP 3 may consist of a mixture of the 1,4,5 and 1,3,4 isomers.
RESULTS
As depicted in Fig. I , carbachol inhibited the increase in somatostatin release induced by dbcAMP and TPA.
Increases in cytosolic 3H-IP 3 content were always noted in the presence of carbachol although dbcAMP and TPA by themselves had no effect. These changes in cytosolic 3H-IP 3 content induced 
